DEAD box [a motif named after its amino acid sequence (Asp-Glu-Ala-Asp)] RNA helicases are known to play key roles in all cellular processes that require modulation of RNA structure. However, in recent years, several of these proteins have been found to function in transcriptional regulation. In the present paper, we shall review the literature demonstrating the action of p68 and, where data are available, p72 as transcriptional co-regulators for a range of transcription factors, namely ERα (oestrogen receptor α), the tumour suppressor p53, the myogenic regulator MyoD and Runx2, a transcription factor essential for osteoblast development. We shall also discuss evidence indicating that, in some cases at least, p68 and p72 have distinct, nonredundant, roles.
Introduction
The DEAD box [a motif named after its amino acid sequence (Asp-Glu-Ala-Asp)] subfamily of RNA helicases is characterized by the presence of several conserved motifs, including the signature DEAD sequence that gives the family its name [1] . These proteins have been shown to play important roles in all aspects of RNA metabolism that include modulation of complex RNA structures or dissociation of large RNP complexes, e.g. pre-mRNA processing, RNA turnover, RNA export, ribosome biogenesis and translation. In these processes, DEAD box proteins act by promoting the formation of optimal RNA structures, often through local, rather than processive, unwinding of RNA or by mediating RNA-protein association/dissociation [2] . However, there is now a growing body of evidence demonstrating that several members of this family also act as transcriptional regulators, and may function by facilitating the recruitment of components of the transcriptional machinery [3] .
p68 (Ddx5) is a nuclear prototypic member of this family and one of the first members for which RNA helicase activity was demonstrated in vitro [4, 5] . However, until relatively recently, the function(s) of p68 remained unclear. Elucidating the function of p68 has been further complicated by the discovery of p72 (Ddx17), a protein with remarkable similarity to p68 (90 % identical in the central core but with different N-and C-termini) [6] . p72 co-localizes and interacts with p68 [7] , also acts as a helicase and apparently shares some but not all functions with p68 [3, 8] . Expression of both p68 and p72 is developmentally regulated [9, 10] and p68 has been associated both with proliferation and with differentiation [11] [12] [13] . Reports that p68 co-purifies with spliceosomes and interacts with the U1 snRNA-5 -splice site duplex [14, 15] , whereas p72 co-purifies with U1 snRNP [16] , together with the observation that the yeast p68/p72 homologue, Dbp2, is required for ribosomal RNA processing, were not surprising given the observed functions of other members of the DEAD box family and the clear need for modulation of RNA structures in these processes. More unexpected were the reports that p68 and p72 act as transcriptional co-activators of ERα (oestrogen receptor α) [17, 18] . Since these initial findings, there have been several studies showing that p68 (and in some cases p72) acts as a co-activator for a range of transcription factors that are themselves highly regulated, and is recruited to promoters of responsive genes under conditions in which these factors are activated, consistent with a role in transcription initiation. Additionally, in some contexts, p68 and p72 can act as promoter-dependent transcriptional repressors [19] . Since there have generally been better reagents available for p68 than for p72, several of the studies have focused purely on p68; other studies have not distinguished between p68 and p72 and have referred to p68/p72 assuming that these proteins have similar, possibly redundant, functions.
Co-activation of ERα by p68 and p72
The first indication that p68 may function in transcription came from a report showing that p68 interacts with and specifically co-activates ERα [17] . Interestingly, p68 RNA helicase activity does not appear to be required for ERα co-activation, suggesting that p68 is multifunctional and that its role in transcription is distinct from that in RNA processing, a function for which its RNA unwinding activity is presumably required. A subsequent study demonstrated that p72 also interacts with and co-activates ERα; this coactivation was found to be enhanced by SRC1 (steroid receptor co-activator 1) and to be dependent on binding to the RNA co-activator SRA (steroid receptor RNA activator). This led to the suggestion that p68/p72 may stimulate ERα activity by acting as a bridge between ERα and SRA/SRC1 [18] . In this study [18] , the activities of p68 and p72 appeared to be indistinguishable. However, in our unpublished work, whereas both p68 and p72 appear to similarly stimulate ERα activity in reporter assays when overexpressed, siRNA (small interfering RNA) knockdown of p68 and p72 had different effects on ERα activity with p72 having a more profound effect on the expression of endogenous ERα-target genes (F. Fuller-Pace and S. Ali, unpublished work), suggesting that these proteins may act differently in a physiological context. In a chromatin immunoprecipitation-based study demonstrating the cyclical, combinatorial, recruitment of cofactors to the promoter of the ERα-target gene pS2 in response to oestrogen, p68 was found to be recruited to this promoter in the first transcriptionally productive cycle together with ERα and the transcription factors TBP (TATAbox-binding protein) and TFIIA (transcription factor IIA), consistent with a key role in transcription initiation [20] . To date, there have been no reports demonstrating p72 recruitment to ERα-responsive promoters, partly due to the lack of p72 reagents but perhaps also based on the assumption that p68 and p72 have analogous functions. Elucidation of the precise role of p72 in ERα transcriptional activation/initiation will rely on the availability of such reagents and on experiments investigating the role of p72 itself, including individual p68-and p72-knockdown experiments.
Co-activation of p53 by p68
Our previous study has demonstrated that p68 is a potent coactivator of the p53 tumour suppressor [21] . p68 was found to interact with p53 in vitro in GST (glutathione transferase) pull-downs, and endogenous p53 and p68 were found to co-immunoprecipitate from nuclear extracts, indicating that the interaction between these proteins is direct and that it occurs physiologically in the cell. p72 and p53 were also found to interact, although more weakly than p68/p53. Moreover, whereas p68 synergized with p53 to stimulate transcription from p53-responsive promoters, p72 was found to be a less potent co-activator of p53 transcriptional activity. Strikingly, siRNA-mediated suppression of p68 expression in cells that harbour wild-type p53 was found to inhibit the induction of p53-target genes in response to DNA damage, and p53-dependent apoptosis, but has no effect on p53 protein stabilization, indicating that p68 plays an important role in the activation of the p53 transcriptional response to DNA damage. These findings show that p68 is an important element in the p53 DNA damage response. In this respect, it is interesting to note that knockdown of p72 expression by siRNA had no discernible effect on the induction of p53-responsive genes by DNA damage, suggesting that the effect on p53 is specific to p68 and again highlighting the fact that p68 and p72 do not function in an analogous manner. Moreover, the striking effect of p68 knockdown on the p53 response to DNA damage demonstrates that, in terms of p53 co-activation, p68 and p72 are not redundant. Additionally, p68 was found to be recruited to p53-responsive promoters in response to DNA damage, supporting the idea of a role for p68 in transcriptional initiation [21] .
p68/p72 as regulators of muscle differentiation/osteoblast differentiation: co-activation of MyoD and Runx2
A recent study has shown that p68 and p72 synergize with SRA to activate MyoD transcriptional activity [13] . Both p68 and p72 were found to co-immunoprecipitate with MyoD and with SRA, leading to suggestions that, as for ERα, p68/p72 may act as a bridge between MyoD and SRA within the transcription initiation complex [22] . These findings, coupled with previous reports of p68 interactions with components of the transcriptional machinery [17, 23] and data from chromatin immunoprecipitation assays demonstrating recruitment of p68 to MyoD and ERα-responsive promoters [13, 20] , have suggested models in which p68 and p72 may be important for the recruitment of specific components of the transcription machinery, including chromatin remodelling factors, and may facilitate formation and stabilization of the initiation complex [22] .
Overexpression of p68 or p72 with SRA was shown to synergize with MyoD to induce myogenic conversion of C3H10T1/2 mouse embryo fibroblasts, whereas simultaneous shRNA (small-hairpin RNA) knockdown of p68 and p72 inhibited the skeletal differentiation of C2C12 cells, indicating that these proteins are important for skeletal-muscle differentiation [13] . Interestingly, these differentiation defects in the knockdown cells were rescued by overexpression of p68 bearing silent mutations that render it refractory to the siRNA knockdown. This finding suggests either that p68 and p72 are redundant in this system or that only p68 is essential for skeletal-muscle differentiation. To fully elucidate the individual functions/importance of p68 and p72, it will be important to generate individual knockdowns of p68 and p72 and determine their effects. Using chromatin immunoprecipitation assays, p68 was shown to be recruited to muscle regulatory regions specifically in differentiated myotubes, consistent with the idea that p68 is recruited to the promoters of actively transcribed genes and is not a general transcriptional co-activator. This finding mirrors similar results obtained in the p53 co-activation study [21] . To date, it is not known whether p72 is similarly recruited to promoters of muscle-specific genes.
In a separate study, p68 was shown to interact with and to co-activate Runx2, and was found to be recruited to a region of the osteocalcin promoter that contains a Runx-binding element [24] . As expected, in C2C12 cells expressing shRNAs knocking down p68 and p72, Runx2 transcriptional activity was inhibited. C2C12 cells are myocyte and osteoblast progenitors and Runx2 is essential for osteoblast development. However, surprisingly, p68/p72 knockdown in these cells accelerated osteoblast maturation, suggesting that, although p68 co-activates Runx2 activity, it inhibits osteoblast differentiation. Moreover, Runx2 itself was found to suppress p68 expression. These findings thus suggest that Runx2 and p68 may control osteoblast differentiation and maturation at multiple levels. It is as yet unclear what role p72 plays in this process, or indeed in skeletal-muscle differentiation. In the MyoD and Runx2 studies, both p68 and p72 were knocked down in the C2C12 cells; in the case of muscle differentiation, p68 expression was able to rescue the defect [13] . Again, studies involving individual p68 and p72 knockdowns/rescue experiments will be required to fully elucidate the potential role of p72 in these processes.
Other functions for p68/p72: can these proteins act as multifunctional adaptors/coupling factors?
A study of the Drosophila p68 orthologue (Rm62) demonstrated a function for p68 in clearance of mRNA transcripts from transcription sites and suggested that p68 was required to facilitate release of RNA to allow the chromatin to be reset to an inactive state, resulting in gene deactivation [25] . Although this study [25] examined the function of p68 in terms of specific gene deactivation, transcript release from chromatin may also be important in situations where transcriptional activation occurs in a cyclical manner requiring the combinatorial recruitment of both co-activators and co-repressors to allow regulation of the duration of activation, as shown for ERα [20] . Such a function would imply a role for p68 beyond that in transcriptional initiation.
Additionally, several reports have implicated both p68 and p72 in pre-mRNA processing [15, 16] and alternative splicing [26, 27] , and the yeast p68/p72 (Dbp2) was found to be important for ribosomal RNA processing [28, 29] . More recently, both proteins were found to be components of the mouse Drosha complex and to be required for primary miRNA (microRNA) and ribosomal RNA processing [30] . Interestingly, although both p68 and p72 were found to be required for mouse survival, a p68 knockout resulted in embryonic lethality on approximately day 11.5, whereas a p72 knockout resulted in neonatal death on postnatal day 2, with the double knockout resulting in earlier lethality. These findings are consistent with previous suggestions that these proteins are important for development [9, 10] and further support the idea that p68 and p72 do not have redundant functions. Thus, whereas for some biological processes p68 and p72 may be redundant [29] , it is clear that for many processes these proteins have different roles.
Moreover, these observations are strongly indicative that p68 and p72 are involved in multiple processes in the cell. The finding that, in all the above studies on p68/p72 as transcriptional co-regulators, ATPase/helicase activity was not required for their action suggests that their function in transcriptional initiation is independent of their action as RNA helicases. This observation, coupled with the many reports indicating that p68, and in some instances p72, binds to several components of both the transcriptional and the splicing machinery [13] [14] [15] 17, 23] implies that these proteins may act as adaptor molecules that not only facilitate the formation of transcriptional initiation complexes but may also act to couple transcription with the post-transcriptional process. This would be consistent with current models of gene expression in which transcriptional initiation, elongation and post-transcriptional RNA processing are coupled [31, 32] and has in fact already been suggested for p68 and p72 [32] . Moreover, the presence of such adaptor molecules would ensure that transcriptional initiation does not occur unless the downstream elongation and processing machinery is in place.
A role for p68/p72 as transcriptional co-regulators in cancer?
Several lines of evidence have suggested that p68 and p72 may play an important role in cancer development. Both p68 and p72 have been reported to be overexpressed in colorectal cancers [33, 34] and to activate β-catenin-dependent transcription [34] , whereas post-translational modifications (ubiquitination and phosphorylation) of p68 have been implicated in tumour development and cell proliferation/transformation [33, 35] . Additionally, the reports demonstrating that p68 and p72 co-activate ERα [17, 18] and that p68 stimulates the transcriptional activity of the p53 tumour suppressor and is important in the p53 response to DNA damage [21] suggest that the ability of p68 and p72 to regulate transcription may play an important role in cancer. Taken together, these findings are consistent with the idea that changes in p68/p72 expression and modifications may be important events in cancer development and/or progression.
